CD34 and Diamond-Blackfan anemia: As with the DBA patient cells, CD34+ hematopoietic stem and progenitor cells (HSPCs) were transduced with RPS19 shRNA, or control, and differentiated in erythropoiesis-promoting media for 5 days, showed reduced mTORC1 kinase activity.